Multi-biofunction of antimicrobial peptide-immobilized silk fibroin nanofiber membrane: Implications for wound healing

Acta Biomaterialia

Volumn 39, Issue , 2016, Pages 146-155

  Song, Dae Woong ^a   Kim, Shin Hwan ^b   Kim, Hyung Hwan ^a   Lee, Ki Hoon ^a   Ki, Chang Seok ^a   Park, Young Hwan ^a,c,d  

^a Seoul National University   (South Korea)

^b Ajinomoto Genexine Corporation   (South Korea)

^c Seoul National University   (South Korea)

^d Seoul National University   (South Korea)

Author keywords

Antimicrobial peptide; Immobilization; Nanofiber; Silk fibroin; Wound dressing

Indexed keywords

CELL PROLIFERATION; ESCHERICHIA COLI; MEMBRANES; NANOFIBERS; PEPTIDES; SURFACE PROPERTIES; TISSUE CULTURE;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL PEPTIDE; BIOFUNCTIONS; CATHELICIDIN; ELECTROSPUNS; IMMOBILISATION; NANOFIBER MEMBRANE; PEPTIDE MOTIFS; SILK FIBROIN; WOUND DRESSINGS;

BIOACTIVITY;

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CYSTEINYLLYSYLARGININYLISOLEUCYLVALYLLYSYLARGININYLISOLEUCYLLYSYLLYSYLTRYPTOPHYLLEUCYLARGININE; LIPOPOLYSACCHARIDE; MALEIMIDE; NANOFIBER; POLYPEPTIDE ANTIBIOTIC AGENT; SILK FIBROIN; THIOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; ARTIFICIAL MEMBRANE; FIBROIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BIOFILM; BIOLOGICAL ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CLICK CHEMISTRY; CONTROLLED STUDY; DRUG EFFECT; ELECTROSPINNING; ESCHERICHIA COLI; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOMODULATION; KERATINOCYTE; MEMBRANE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN IMMOBILIZATION; PROTEIN MOTIF; PSEUDOMONAS AERUGINOSA; RAW 264.7 CELL LINE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURFACE PROPERTY; WOUND DRESSING; WOUND HEALING; ANIMAL; ARTIFICIAL MEMBRANE; BACTERIUM; BIOSYNTHESIS; BOMBYX; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; MACROPHAGE; METABOLISM; MOUSE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; BOMBYX; FIBROINS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANES, ARTIFICIAL; MICE; NANOFIBERS; RAW 264.7 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84966709697     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2016.05.008     Document Type: Article

References (60)

1. [1] Sen, C.K., Gordillo, G.M., Roy, S., Kirsner, R., Lambert, L., Hunt, T.K., Gottrup, F., Gurtner, G.C., Longaker, M.T., Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 17 (2009), 763–771.
2. [2] Edwards, R., Harding, K.G., Bacteria and wound healing. Curr. Opin. Infect. Dis. 17 (2004), 91–96.
3. [3] Siedenbiedel, F., Tiller, J.C., Antimicrobial polymers in solution and on surfaces: overview and functional principles. Polymers 4 (2012), 46–71.
4. [4] Mogosanu, G.D., Grumezescu, A.M., Natural and synthetic polymers for wounds and burns dressing. Int. J. Pharm. 463 (2014), 127–136.
5. [5] Abrigo, M., McArthur, S.L., Kingshott, P., Electrospun nanofibers as dressings for chronic wound care: advances, challenges, and future prospects. Macromol. Biosci. 14 (2014), 772–792.
6. [6] Vepari, C., Kaplan, D.L., Silk as a biomaterial. Prog. Polym. Sci. 32 (2007), 991–1007.
7. [7] Murphy, A.R., Kaplan, D.L., Biomedical applications of chemically-modified silk fibroin. J. Mater. Chem. 19 (2009), 6443–6450.
8. [8] Gil, E.S., Panilaitis, B., Bellas, E., Kaplan, D.L., Functionalized silk biomaterials for wound healing. Adv. Healthc. Mater. 2 (2013), 206–217.
9. [9] Wang, Z.G., Wan, L.S., Liu, Z.M., Huang, X.J., Xu, Z.K., Enzyme immobilization on electrospun polymer nanofibers: an overview. J. Mol. Catal. B-Enzym. 56 (2009), 189–195.
10. [10] Kaur, J., Rajkhowa, R., Afrin, T., Tsuzuki, T., Wang, X., Facts and myths of antibacterial properties of silk. Biopolymers 101 (2014), 237–245.
11. [11] Nikaido, H., Multidrug resistance in bacteria. Annu. Rev. Biochem. 78 (2009), 119–146.
12. [12] Thorsteinsson, T., Masson, M., Kristinsson, K.G., Hjalmarsdottir, M.A., Hilmarsson, H., Loftsson, T., Soft antimicrobial agents: synthesis and activity of labile environmentally friendly long chain quaternary ammonium compounds. J. Med. Chem. 46 (2003), 4173–4181.
13. [13] Atiyeh, B.S., Costagliola, M., Hayek, S.N., Dibo, S.A., Effect of silver on burn wound infection control and healing: review of the literature. Burns 33 (2007), 139–148.
14. [14] Kong, M., Chen, X.G., Xing, K., Park, H.J., Antimicrobial properties of chitosan and mode of action: a state of the art review. Int. J. Food Microbiol. 144 (2010), 51–63.
15. [15] Mooney, E.K., Lippitt, C., Friedman, J., Silver dressings. Plast. Reconstr. Surg. 117 (2006), 666–669.
16. [16] Loh, J.W., Yeoh, G., Saunders, M., Lim, L.Y., Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. Toxicol. Appl. Pharmacol. 249 (2010), 148–157.
17. [17] Poon, V.K., Burd, A., In vitro cytotoxicity of silver: implication for clinical wound care. Burns 30 (2004), 140–147.
18. [18] Park, M.V., Neigh, A.M., Vermeulen, J.P., de la Fonteyne, L.J., Verharen, H.W., Briede, J.J., van Loveren, H., de Jong, W.H., The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 32 (2011), 9810–9817.
19. [19] Hancock, R.E., Sahl, H.G., Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24 (2006), 1551–1557.
20. [20] Zasloff, M., Antimicrobial peptides of multicellular organisms. Nature 415 (2002), 389–395.
21. [21] Parisien, A., Allain, B., Zhang, J., Mandeville, R., Lan, C.Q., Novel alternatives to antibiotics: bacteriophages, bacterial cell wall hydrolases, and antimicrobial peptides. J. Appl. Microbiol. 104 (2008), 1–13.
22. [22] Cleveland, J., Montville, T.J., Nes, I.F., Chikindas, M.L., Bacteriocins: safe, natural antimicrobials for food preservation. Int. J. Food Microbiol. 71 (2001), 1–20.
23. [23] Fox, J.L., Antimicrobial peptides stage a comeback. Nat. Biotechnol. 31 (2013), 379–382.
24. [24] Wang, G., Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 283 (2008), 32637–32643.
25. [25] Jacob, B., Park, I.S., Bang, J.K., Shin, S.Y., Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity. J. Pept. Sci. 19 (2013), 700–707.
26. [26] Mishra, B., Epand, R.F., Epand, R.M., Wang, G., Structural location determines functional roles of the basic amino acids of KR-12, the smallest antimicrobial peptide from human cathelicidin LL-37. RSC Adv. 3 (2013), 19560–19571.
27. [27] Vandamme, D., Landuyt, B., Luyten, W., Schoofs, L., A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell. Immunol. 280 (2012), 22–35.
28. [28] Rosenfeld, Y., Papo, N., Shai, Y., Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 281 (2006), 1636–1643.
29. [29] Mookherjee, N., Brown, K.L., Bowdish, D.M., Doria, S., Falsafi, R., Hokamp, K., Roche, F.M., Mu, R., Doho, G.H., Pistolic, J., Powers, J.P., Bryan, J., Brinkman, F.S., Hancock, R.E., Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 176 (2006), 2455–2464.
30. [30] Tjabringa, G.S., Aarbiou, J., Ninaber, D.K., Drijfhout, J.W., Sorensen, O.E., Borregaard, N., Rabe, K.F., Hiemstra, P.S., The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J. Immunol. 171 (2003), 6690–6696.
31. [31] Heilborn, J.D., Nilsson, M.F., Kratz, G., Weber, G., Sorensen, O., Borregaard, N., Stahle-Backdahl, M., The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120 (2003), 379–389.
32. [32] Tokumaru, S., Sayama, K., Shirakata, Y., Komatsuzawa, H., Ouhara, K., Hanakawa, Y., Yahata, Y., Dai, X., Tohyama, M., Nagai, H., Yang, L., Higashiyama, S., Yoshimura, A., Sugai, M., Hashimoto, K., Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J. Immunol. 175 (2005), 4662–4668.
33. [33] Shaykhiev, R., Beisswenger, C., Kandler, K., Senske, J., Puchner, A., Damm, T., Behr, J., Bals, R., Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005), L842–L848.
34. [34] Akiyama, T., Niyonsaba, F., Kiatsurayanon, C., Nguyen, T.T., Ushio, H., Fujimura, T., Ueno, T., Okumura, K., Ogawa, H., Ikeda, S., The human cathelicidin LL-37 host defense peptide upregulates tight junction-related proteins and increases human epidermal keratinocyte barrier function. J. Innate Immun. 6 (2014), 739–753.
35. [35] Carretero, M., Escamez, M.J., Garcia, M., Duarte, B., Holguin, A., Retamosa, L., Jorcano, J.L., Rio, M.D., Larcher, F., In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J. Invest. Dermatol. 128 (2008), 223–236.
36. [36] Ramos, R., Silva, J.P., Rodrigues, A.C., Costa, R., Guardao, L., Schmitt, F., Soares, R., Vilanova, M., Domingues, L., Gama, M., Wound healing activity of the human antimicrobial peptide LL37. Peptides 32 (2011), 1469–1476.
37. [37] Maher, S., McClean, S., Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro. Biochem. Pharmacol. 71 (2006), 1289–1298.
38. [38] Han, F.F., Liu, Y.F., Xie, Y.G., Gao, Y.H., Luan, C., Wang, Y.Z., Antimicrobial peptides derived from different animals: comparative studies of antimicrobial properties, cytotoxicity and mechanism of action. World J. Microbiol. Biotechnol. 27 (2011), 1847–1857.
39. [39] Bacalum, M., Radu, M., Cationic antimicrobial peptides cytotoxicity on mammalian cells: an analysis using therapeutic index integrative concept. Int. J. Pept. Res. Ther. 21 (2015), 47–55.
40. [40] Gronberg, A., Zettergren, L., Agren, M.S., Stability of the cathelicidin peptide LL-37 in a non-healing wound environment. Acta Derm. Venereol. 91 (2011), 511–515.
41. [41] Li, X., Li, P., Saravanan, R., Basu, A., Mishra, B., Lim, S.H., Su, X., Tambyah, P.A., Leong, S.S., Antimicrobial functionalization of silicone surfaces with engineered short peptides having broad spectrum antimicrobial and salt-resistant properties. Acta Biomater. 10 (2014), 258–266.
42. [42] Mishra, B., Basu, A., Chua, R.R.Y., Saravanan, R., Tambyah, P.A., Ho, B., Chang, M.W., Leong, S.S.J., Site specific immobilization of a potent antimicrobial peptide onto silicone catheters: evaluation against urinary tract infection pathogens. J. Mater. Chem. B 2 (2014), 1706–1716.
43. [43] Lim, K., Chua, R.R., Bow, H., Tambyah, P.A., Hadinoto, K., Leong, S.S., Development of a catheter functionalized by a polydopamine peptide coating with antimicrobial and antibiofilm properties. Acta Biomater. 15 (2015), 127–138.
44. [44] Gao, G., Lange, D., Hilpert, K., Kindrachuk, J., Zou, Y., Cheng, J.T., Kazemzadeh-Narbat, M., Yu, K., Wang, R., Straus, S.K., Brooks, D.E., Chew, B.H., Hancock, R.E., Kizhakkedathu, J.N., The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides. Biomaterials 32 (2011), 3899–3909.
45. [45] Holmberg, K.V., Abdolhosseini, M., Li, Y., Chen, X., Gorr, S.U., Aparicio, C., Bio-inspired stable antimicrobial peptide coatings for dental applications. Acta Biomater. 9 (2013), 8224–8231.
46. [46] Lin, W., Junjian, C., Chengzhi, C., Lin, S., Sa, L., Li, R., Yingjun, W., Multi-biofunctionalization of a titanium surface with a mixture of peptides to achieve excellent antimicrobial activity and biocompatibility. J. Mater. Chem. B 3 (2015), 30–33.
47. [47] Tan, X.W., Goh, T.W., Saraswathi, P., Nyein, C.L., Setiawan, M., Riau, A., Lakshminarayanan, R., Liu, S., Tan, D., Beuerman, R.W., Mehta, J.S., Effectiveness of antimicrobial peptide immobilization for preventing perioperative cornea implant-associated bacterial infection. Antimicrob. Agents Chemother. 58 (2014), 5229–5238.
48. [48] Pedrosa, M., Mouro, C., Nogueira, F., Vaz, J., Gouveia, I., Comparison of the antibacterial activity of modified-cotton with magainin I and LL-37 with potential as wound-dressings.J. Appl. Polym. Sci.., 131, 2014.
49. [49] Gomes, A.P., Mano, J.F., Queiroz, J.A., Gouveia, I.C., Incorporation of antimicrobial peptides on functionalized cotton gauzes for medical applications. Carbohydr. Polym. 127 (2015), 451–461.
50. [50] Heunis, T.D., Smith, C., Dicks, L.M., Evaluation of a nisin-eluting nanofiber scaffold to treat Staphylococcus aureus-induced skin infections in mice. Antimicrob. Agents Chemother. 57 (2013), 3928–3935.
51. [51] Rapsch, K., Bier, F.F., Tadros, M., von Nickisch-Rosenegk, M., Identification of antimicrobial peptides and immobilization strategy suitable for a covalent surface coating with biocompatible properties. Bioconjug. Chem. 25 (2014), 308–319.
52. [52] Bai, L.Q., Zhu, L.J., Min, S.J., Liu, L., Cai, Y.R., Yao, J.M., Surface modification and properties of Bombyx mori silk fibroin films by antimicrobial peptide. Appl. Surf. Sci. 254 (2008), 2988–2995.
53. [53] Gabriel, M., Nazmi, K., Veerman, E.C., Nieuw Amerongen, A.V., Zentner, A., Preparation of LL-37-grafted titanium surfaces with bactericidal activity. Bioconjug. Chem. 17 (2006), 548–550.
54. [54] Hilpert, K., Elliott, M., Jenssen, H., Kindrachuk, J., Fjell, C.D., Korner, J., Winkler, D.F., Weaver, L.L., Henklein, P., Ulrich, A.S., Chiang, S.H., Farmer, S.W., Pante, N., Volkmer, R., Hancock, R.E., Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem. Biol. 16 (2009), 58–69.
55. [55] Bagheri, M., Beyermann, M., Dathe, M., Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Antimicrob. Agents Chemother. 53 (2009), 1132–1141.
56. [56] Dong, L., Yang, J.J., Wang, Y., Liu, H., Mu, L.X., Lin, D.H., Lai, R., Structure-function relationship of antimicrobial peptide cathelicidin Pc-CATH1. Nat. Prod. Bioprospect. 2 (2012), 81–86.
57. [57] Tossi, A., Sandri, L., Giangaspero, A., Amphipathic, α-helical antimicrobial peptides. Biopolymers 55 (2000), 4–30.
58. [58] Zhang, W., Liu, H.T., MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12 (2002), 9–18.
59. [59] Efimova, T., Broome, A.M., Eckert, R.L., A regulatory role for p38 delta MAPK in keratinocyte differentiation. Evidence for p38 delta-ERK1/2 complex formation.J. Biol. Chem.., 278, 2003, 34277–34285.
60. [60] Sharma, G.D., He, J., Bazan, H.E., P38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J. Biol. Chem. 278 (2003), 21989–21997.